| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Nov―25 |
Recombinant receptor-binding motif of spike COVID-19 vaccine candidate induces SARS-CoV-2 neutralizing antibody response |
Hossein Samiei-Abianeh, Shahram Nazarian, Emad Kordbacheh, Alireza Felegary |
| 2 |
[GO] |
2024―Aug―19 |
Performance of protein N linear epitopes in serodiagnosis of COVID-19 infection |
Sahar Farajnia, Nazli Khajenasiri, Safar Farajnia, Farzin Seyrafi, Nasim Bakhtiyari |
| 3 |
[GO] |
2024―Aug―19 |
Effectiveness of dolutegravir in moderate severity COVID-19 patients: A single-center, randomized, double-blind, placebo-controlled trial |
Hamideh Abbaspour Kasgari, Siavash Moradi, Ahmad Alikhani, Nasim Ahmadian |
| 4 |
[GO] |
2024―Aug―19 |
Interaction of toll-like receptors and ACE-2 with different variants of SARS-CoV-2: A computational analysis |
Azadeh Zahmatkesh, Elham Salmasi, Reza Gholizadeh |
| 5 |
[GO] |
2024―Jun―24 |
Effect of parenteral L-carnitine in hospitalized patients with moderate to severe COVID-19: A randomized double-blind clinical trial |
Farnaz Naeimzadeh, Armin Sadeghi, Seiedhadi Saghaleini, Parvin Sarbakhsh, Ata Mahmoodpoor, Afshin Gharekhani |
| 6 |
[GO] |
2024―May―16 |
COVID-19: An overview on possible transmission ways, sampling matrices and diagnosis |
Elina Armani Khatibi, Nastaran Farshbaf Moghimi, Elaheh Rahimpour |
| 7 |
[GO] |
2023―Aug―16 |
Mosaic Vaccine Design Targeting Mutational Spike Protein of SARS-COV-2 : an Immunoinformatics Approaches |
Ysrafil Ysrafil, Arlan K Imran, Prisca Syafriani Wicita, Vyani Kamba, Fihrina Mohamad, Ismail Ismail, et al. (+8) Ayyub Harly Nurung, Noviyanty Indjar Gama, Sari Eka Pratiwi, Indwiani Astuti, Deepak Chandran, Fahad A Alhumaydhi, Firzan Nainu, Talha Bin Emran |
| 8 |
[GO] |
2023―Aug―16 |
SARS-CoV-2 vaccine-triggered autoimmunity: Molecular mimicry and/or bystander activation of the immune system |
Azam Safary, Mostafa Akbarzadeh-Khiavi, Jaleh Barar, Yadollah Omidi |
| 9 |
[GO] |
2023―Feb―20 |
Functionality of immune cells in COVID-19 infection: development of cell-based therapeutics |
Maryam Sayahinouri, Sahar Mashayekhi Firouz, Amin Ebrahimi Sadrabadi, Mina Masoudnia, Mahnaz Abdolahi, Fatemeh Jafarzadeh, et al. (+5) Meshkat Nouripour, Sana Mirzazadeh, Nazanin Zangeneh, Arsalan Jalili, Nasser Aghdami |
| 10 |
[GO] |
2022―Aug―01 |
COVID-19: Artificial sputum, respiratory obstruction method and screening of pyolitic and antihypoxic drugs |
Aleksandr L. Urakov, Natalya A. Urakova, Ilnur I. Yagudin, Milena D. Svetova, Darya O. Suntsova |
| 11 |
[GO] |
2022―May―14 |
An opinion on the impacts of COVID-19 worldwide |
Robert C. Speth |
| 12 |
[GO] |
2022―Mar―28 |
SARS-CoV-2 and probable lung cancer risk |
Sajad Khiali, Afra Rezagholizadeh, Taher Entezari-Maleki |
| 13 |
[GO] |
2022―Mar―28 |
Designing multi-epitope based peptide vaccine candidates against SARS-CoV-2 using immunoinformatics approach |
Ysrafil Ysrafil, Zulfiayu Sapiun, Indwiani Astuti, Mohammad Anas Anasiru, Nangsih Sulastri Slamet, Hartati Hartati, et al. (+2) Fadli Husain, Sukmawati Ahmad Damiti |
| 14 |
[GO] |
2021―Dec―01 |
The active lung microbiota landscape of COVID-19 patients through the metatranscriptome data analysis |
Yang Han, Zhilong Jia, Jinlong Shi, Weidong Wang, Kunlun He |
| 15 |
[GO] |
2021―Dec―01 |
Molecular docking, molecular dynamics simulation, and ADMET analysis of levamisole derivatives against the SARS-CoV-2 main protease (MPro) |
Khalil EL Khatabi, Ilham Aanouz, Marwa Alaqarbeh, Mohammed Aziz Ajana, Tahar Lakhlifi, Mohammed Bouachrine |
| 16 |
[GO] |
2021―Sep―30 |
Gut microbial signature and gut-lung axis: A possible role in the therapy of COVID-19 |
Ata Mahmoodpoor, Ali Shamekh, Sarvin Sanaie |
| 17 |
[GO] |
2021―Sep―30 |
A fuzzy logic-based computational method for the repurposing of drugs against COVID-19 |
Yosef Masoudi-Sobhanzadeh, Hosein Esmaeili, Ali Masoudi-Nejad |
| 18 |
[GO] |
2021―Jul―06 |
Phenomenology of human collective consciousness confronting COVID-19: The trace of the pandemic in the humane mind |
Alireza Farnam |
| 19 |
[GO] |
2021―Jul―06 |
Would the interference phenomenon be applied as an alternative option for prophylaxis against COVID-19? |
Mohammad Hossein Ahmadi |
| 20 |
[GO] |
2020―Dec―19 |
A domain-based vaccine construct against SARS-CoV-2, the causative agent of COVID-19 pandemic: development of self-amplifying mRNA and peptide vaccines |
Mohammad Mostafa Pourseif, Sepideh Parvizpour, Behzad Jafari, Jaber Dehghani, Behrouz Naghili, Yadollah Omidi |
| 21 |
[GO] |
2020―Sep―14 |
Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial |
Khalil Ansarin, Ramin Tolouian, Mohammadreza Ardalan, Ali Taghizadieh, Mojtaba Varshochi, Soheil Teimouri, et al. (+5) Tahere Vaezi, Hamed Valizadeh, Parviz Saleh, Saeid Safiri, Kenneth R. Chapman |
| 22 |
[GO] |
2020―Jul―18 |
Computational-based drug repurposing methods in COVID-19 |
Yosef Masoudi-Sobhanzadeh |
| 23 |
[GO] |
2020―Jul―18 |
COVID-19 clinical implications: the significance of nanomedicine |
Jaleh Barar |
| 24 |
[GO] |
2020―Jul―18 |
COVID-19 pandemic may fuel academic bullying |
Morteza Mahmoudi, Loraleigh Keashly |
